Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer

Figure 9

The schematic diagram of exosomal miR-651/ATG3 on cervical cancer progression.